Halifax Health in Florida is First in the U.S. to Treat Patients with Cancer Using the Accuray Radixact Radiation Delivery System and VitalHold Technology - StockTitan
| CRAD-B Stock | SEK 30.90 0.60 1.98% |
About 53% of C Rad's investors are presently thinking to get in. The analysis of current outlook of investing in C Rad AB suggests that some traders are interested regarding C Rad's prospects. The current market sentiment, together with C Rad's historical and current headlines, can help investors time the market. In addition, many technical investors use C Rad AB stock news signals to limit their universe of possible portfolio assets.
CRAD-B |
Halifax Health in Florida is First in the U.S. to Treat Patients with Cancer Using the Accuray Radixact Radiation Delivery System and VitalHold Technology StockTitan
Read at news.google.com
 |
C Rad Fundamental Analysis
We analyze C Rad's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of C Rad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of C Rad based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
C Rad is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
C Rad AB Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with C Rad stock to make a market-neutral strategy. Peer analysis of C Rad could also be used in its relative valuation, which is a method of valuing C Rad by comparing valuation metrics with similar companies.
Peers
C Rad Related Equities
| BOUL | Boule Diagnostics | 6.59 | ||||
| CEVI | CellaVision | 1.15 | ||||
| BIOT | Biotage AB | 0.98 | ||||
| BONEX | Bonesupport Holding | 0.06 | ||||
| RAY-B | RaySearch Laboratories | 0.25 |
Complementary Tools for CRAD-B Stock analysis
When running C Rad's price analysis, check to measure C Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy C Rad is operating at the current time. Most of C Rad's value examination focuses on studying past and present price action to predict the probability of C Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move C Rad's price. Additionally, you may evaluate how the addition of C Rad to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |